Experience

Davis Polk advised the joint lead managers in connection with the offering of the $400 million 2.437% bonds due 2023 by Shangdong Hi-Speed Group (Hong Kong) Co., Limited with the benefit of…

Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,400,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common…

Davis Polk advised Morgan Stanley on the recommencement of its SEC-registered financing programs and the related filing of its universal shelf registration statement, which includes a…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering by Pacific Gas and Electric Company of $1.45 billion aggregate…

Davis Polk advised NatWest Group plc, a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered shelf takedown of £1 billion aggregate…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $700 million aggregate principal amount of 3.750% notes due 2030 by AngloGold Ashanti Holdings plc,…

Davis Polk advised Soltec Power Holdings, S.A. on the Rule 144A/Regulation S initial public offering by Soltec Power Holdings of 31,146,717 of its ordinary shares. The initial public…

Davis Polk advised Delek Overriding Royalty Leviathan Ltd., on its Rule 144A offering of $180 million principal amount of 7.494% senior secured notes due 2023. The notes are secured by…

Davis Polk advised the underwriters in connection with a Regulation S offering by Hubei Science & Technology Investment Group (Hong Kong) Company Limited, a wholly owned subsidiary of…

Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.  Xspray was founded in 2003…